https://www.news-medical.net/news/20221103/Study-explores-the-potential-use-of-anti-thymic-stromal-lymphopoietin-monoclonal-antibody-as-an-adjuvant-in-allergic-immunotherapy.aspx
0
0
47 words
0
Comments
A new study investigated the impact of a monoclonal anti-thymic stromal lymphopoietin (TSLP) antibody on subcutaneous allergen immunotherapy (SCIT) efficacy among patients with allergic rhinitis.
You are the first to view
Create an account or login to join the discussion